DJIA 17,055.87 -116.81 -0.68%
NASDAQ 4,508.69 -19.00 -0.42%
S&P 500 1,982.77 -11.52 -0.58%
market minute promo

Repligen Corp (NASDAQ: RGEN)

19.66 -0.04 (-0.20%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

RGEN $19.66 -0.20%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $19.60
Previous Close $19.70
Daily Range $19.47 - $19.97
52-Week Range $9.89 - $24.68
Market Cap $641.9M
P/E Ratio 38.63
Dividend (Yield) $0.00 (0.0%)
Volume 337,751
Average Daily Volume 385,193
Current FY EPS $0.29

Sector

Healthcare

Industry

Drugs

Repligen Corp (RGEN) Description

A biopharmaceutical company focused on the development of novel therapeutics for the treatment of diseases of the central nervous system. Website: http://www.repligen.com/

News & Commentary Rss Feed

3 Stocks to Get on Your Watchlist

A biopharmaceutical company with an upcoming FDA decision, a discount store attracting possible buyout interest, and a potentially overvalued life sciences company are this week's three must-watch stocks.

3 Big-Volume Health Care Stocks in Breakout Territory

Repligen's (RGEN) CEO Walter Herlihy on Q2 2014 Results - Earnings Call Transcript

Sector Update: Health Care

Sector Update: Health-Care Shares Higher Pre-Market

Repligen (RGEN) Q2 2014 Results - Earnings Call Webcast

Repligen (RGEN) Shares March Higher, Can It Continue? - Tale of the Tape

Repligen (RGEN) Shares March Higher, Can It Continue? - Tale of the Tape

Stocks Hitting 52-Week Highs

XBI, MNKD, MACK, RGEN: ETF Outflow Alert

Why Repligen Corporation Shares Vaulted Higher

Repligen shares soar after going shopping, but here's what shareholders may really want to keep their eyes on.

See More RGEN News...

RGEN's Top Competitors

RGEN $19.66 (-0.20%)
Current stock: RGEN
AMGN $140.68 (-1.06%)
Current stock: AMGN
GILD $105.39 (-0.08%)
Current stock: GILD
BIIB $332.24 (0.75%)
Current stock: BIIB